CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes

Elimination of IL-10-Inducing T-Helper Epitopes from an IGFBP-2 Vaccine Ensures Potent Antitumor Activity

(2014) D. L. Cecil et al.   CANCER RESEARCH

T-Cell-Receptor-Dependent Signal Intensity Dominantly Controls CD4+ T Cell Polarization In Vivo

(2014) Nicholas van Panhuys et al.   IMMUNITY

Essentials of Th17 cell commitment and plasticity

(2013) P. Muranski et al.   BLOOD

A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)

(2013) C. L. Slingluff et al.   CLINICAL CANCER RESEARCH

Lack of expression of an alternative CD20 transcript variant in circulating B cells from patients with pemphigus

(2013) Clémentine Gamonet et al.   EXPERIMENTAL DERMATOLOGY

Nonclassical Antigen-Processing Pathways Are Required for MHC Class II-Restricted Direct Tumor Recognition by NY-ESO-1-Specific CD4+ T Cells

(2013) J. Matsuzaki et al.   Cancer Immunology Research

Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells

(2013) George W. Small et al.   PeerJ

High frequency of T cells specific for cryptic epitopes in melanoma patients

(2013) Rikke Sick Andersen et al.   OncoImmunology

Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms

(2012) Lixin Zhang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells

(2012) Ilseyar Akhmetzyanova et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Human TH17 Immune Cells Specific for the Tumor Antigen MAGE-A3 Convert to IFN- -Secreting Cells as They Differentiate into Effector T Cells In Vivo

(2012) A. Hamai et al.   CANCER RESEARCH

Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination

(2012) E. H. J. G. Aarntzen et al.   CANCER RESEARCH

Splicing in oncogenesis and tumor suppression

(2012) Daisuke Kaida et al.   CANCER SCIENCE

Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor

(2012) M. Dosset et al.   CLINICAL CANCER RESEARCH

Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response

(2012) Y. Godet et al.   CLINICAL CANCER RESEARCH

The Cancer Exome Generated by Alternative mRNA Splicing Dilutes Predicted HLA Class I Epitope Density

(2012) Thomas Stranzl et al.   PLoS One

Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance

(2010) C. Henry et al.   BLOOD

CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes

(2010) R. Bos et al.   CANCER RESEARCH

Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors

(2010) Jinfang Zhu et al.   IMMUNOLOGICAL REVIEWS

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer

(2009) F. M. Speetjens et al.   CLINICAL CANCER RESEARCH

Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients

(2009) Jun-ichi Kobayashi et al.   Journal of Translational Medicine

ASTD: The Alternative Splicing and Transcript Diversity database

(2008) Gautier Koscielny et al.   GENOMICS

Multiple roles for CD4+T cells in anti-tumor immune responses

(2008) Richard Kennedy et al.   IMMUNOLOGICAL REVIEWS